½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹KDR (phospho-Tyr1059)¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹KDR (phospho-Tyr1059)¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW10605
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º Íÿ¹KDR (phospho-Tyr1059)¶à¿Ë¡¿¹Ìå

Ó¢ÎÄÃû³Æ£º Anti-KDR (phospho-Tyr1059) rabbit polyclonal antibody

±ð    Ãû£º FLK1; CD309; VEGFR; KDR; VEGFR2

Ïà¹ØÀà±ð£º Ò»¿¹

´¢    ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

ËÞ    Ö÷£º Rabbit

¿¹    Ô­£º KDR (phospho-Tyr1059)

·´Ó¦ÖÖÊô£º Human, Mouse, Rat

±ê ¼Ç Î Unconjugate

¿Ë¡ÀàÐÍ£º rabbit polyclonal

¼¼Êõ¹æ¸ñ

Background:

Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions

Applications:

WB

Name of antibody:

KDR (phospho-Tyr1059)

Immunogen:

Synthetic peptide of human KDR (phospho-Tyr1059)

Full name:

kinase insert domain receptor (a type III receptor tyrosine kinase) (phospho-Tyr1059)

Synonyms£º

FLK1; CD309; VEGFR; KDR; VEGFR2

SwissProt:

P35968

WB Predicted band size:

152 kDa

WB Positive control:

HT29 cells treated with SCF-1

WB Recommended dilution:

500-1000



¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿